Developed by Inovio Pharmaceuticals, the medicine treats a rare condition caused by HPV. The approval paves the way for an ...

Evolutionary changes in key protein synthesis enzyme, isoleucyl-tRNA synthetase (IleRS), may help bacteria fine-tune how ...

Annual Awards Program Recognizes Breakthrough Life Sciences & Biotechnology Innovation Around the WorldLOS ANGELES, Nov. 05, ...

Backed by up to £300 million in funding and model commitments, Britain’s new AI Biosecurity Lab highlights the race to ...

Commercial fishing has had a profound impact on the diversity and sustainability of fish populations. The fishing industry ...

The presence of all five nitrogenous bases—which are the fundamental building blocks of DNA and RNA—has been confirmed for ...

Hidden mechanisms in extracellular DNA spotted by researchers at Aarhus University enable dormant viruses to become ...

Azenta reported past investments to expand its GENEWIZ business, licensing Elegen's cell-free DNA synthesis technology and ...

The biggest challenges in sourcing synthetic DNA are turnaround time, customisation, logistics and supply reliability” ...

Gladstone Institutes scientists found that type VI retrons increase single-stranded DNA production after phage infection, ...

An update from Azenta ( ) is now available. On October 28, 2026, Azenta entered into an integrated technology, equipment and license arrangement and a supply agreement with Elegen ...

Azenta, Inc. announced on October 30, 2026, two strategic investments intended to advance the next phase of growth for its ...